L

Laboratorios Richmond SACIF
BCBA:RICH

Watchlist Manager
Laboratorios Richmond SACIF
BCBA:RICH
Watchlist
Price: 1 935 ARS -0.51%
Market Cap: 156.3B ARS

Laboratorios Richmond SACIF
Investor Relations

Laboratorios Richmond SACIF manufactures pharmaceutical products. The company is headquartered in Buenos Aires, Buenos Aires. The company went IPO on 2017-12-22. The firm's product categories include: Antiviral, under the brands Ciganclor, Lazinevir, Leuzan, Mivuten, Probirase, Protease, Selmivir, Trivenz, Virontar, Virontar N, Virontar 600, Vuclodir, Zepril, Zetavudin, and Zetrotax; Oncologi and Oncohematologic, under the brands Bemux, Capecit, Doxetal, Drifen, Espasevit, Fontrax, Gezt, and Monofer, among others; Cardiovascular, under the brands Amze 5, Amze 10, Antiplaq, Bilip 10, Bilip 20, Tacardia, and Timezol 20, among others; Neuropsychiatric, under the brands Dalam 15, Dolofrix 10, Donepes 5, and Prilben 10, among others, as well as Hospital, under the brands Amidiaz, Dalam, and Fentax, among others.

Show more
No Earnings Calls Available

Management

Juan Manuel Artola
CEO & Director
No Bio Available
Ruben Jorge Alvarez
Chief Financial Officer
No Bio Available

Contacts

Address
BUENOS AIRES
Buenos Aires
Bouchard 680
Contacts
+541155551600
www.richmondlab.com